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Abstract
Background: Physical inactivity (PIA) is an important risk factor for many chronic conditions and therefore might
increase healthcare utilization and costs. This study aimed to analyze the association of PIA using device assessed
and self-reported physical activity (PA) data with direct healthcare costs.
Methods: Cross-sectional data was retrieved from the population based KORA FF4 study (Cooperative Health
Research in the Region of Augsburg) that was conducted in southern Germany from 2013 to 2014 (n = 2279).
Self-reported PA was assessed with two questions regarding sports related PA in summer and winter and
categorized into “high activity”, “moderate activity”, “low activity” and “no activity”. In a subsample (n = 477), PA
was assessed with accelerometers and participants were categorized into activity quartiles (“very high”, “high”,
“low” and “very low”) according to their mean minutes per day spent in light intensity, or in moderate-vigorous
PA (MVPA). Self-reported healthcare utilization was used to estimate direct healthcare costs. We regressed
direct healthcare costs on PA using a two-part gamma regression, adjusted for age, sex and socio-demographic
variables. Additional models, including and excluding potential additional confounders and effect mediators
were used to check the robustness of the results.
Results: Annual direct healthcare costs of individuals who reported no sports PA did not differ from those who
reported high sports PA [+€189, 95% CI: -188, 598]. In the subsample with accelerometer data, participants with
very low MVPA had significantly higher annual costs than participants with very high MVPA [+€986, 95% CI: 15, 1982].
Conclusion: Device assessed but not self-reported PIA was associated with higher direct healthcare costs. The magnitude
and significance of the association depended on the choice of covariates in the regression models. Larger studies with
device assessed PA and longitudinal design are needed to be able to better quantify the impact of PIA on direct
healthcare costs.
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Background
Physical inactivity (PIA) is prevalent in 31% of the
world’s population, and has been identified as the
fourth leading risk factor for global mortality causing
6% of deaths worldwide [1–3].
Valid estimates on the financial burden of PIA are rare
due to the complexity of measuring PIA and healthcare
costs in large-scale studies [4]. However, quantification
of the financial burden of PIA will provide evidence for
Public Health policy makers to prioritize efforts to in-
crease PA on a population level.
Previous studies have estimated the percentage of
direct healthcare costs associated with PIA using a
population-attributable fraction approach that com-
bines risk, prevalence, and aggregate cost estimates
from various sources [5–10]. For example, Allender et
al. [5] used information from the WHO global burden
of disease report of 2002 and concluded that the
costs of PIA due to mortality and morbidity to the
National Health Service in the UK is £1.06 billion
annually.
Another approach to calculate direct healthcare costs
is to use individual data linked to healthcare expenditure
data. This approach is called bottom-up approach and is
overcoming many of the limitations associated with esti-
mates calculated using a population-attributable fraction
approach [11, 12]. Carlson et al. [11] used physical activ-
ity (PA) data from the National Health Interview Survey
merged with data from the Medical Expenditure Panel
Survey and used a four-part econometric model to cal-
culate mean differences in direct healthcare costs be-
tween inactive and active adults. In this study, inactive
subjects had $1437 higher overall direct healthcare costs
as compared to active.
PA is an ambiguous concept as its forms and intensity
levels vary substantially. Therefore, the measurement
through self-report is highly vulnerable to biases in
perception and reporting that can lead to under- or
overestimation of PA [13]. Alternatively, PA can be mea-
sured using devises such as accelerometers. These de-
vices have gained popularity due to their ability to
capture large amounts of information on individual ac-
tivity profiles in population-based studies. Among sev-
eral strengths of accelerometers, a limitation is that they
do not provide any contextual information (i.e. type of
sport, additional equipment used, for example,
weights used for weight training) [14]. Neither the de-
vice assessed, nor the self-reported assessment
method alone gives a valid and comprehensive picture
of people’s PA level.
The aim of this study is to analyze the association be-
tween PIA and direct healthcare costs using both,
self-report and device assessed measures of PA in a large
population-based cross-sectional study.
Methods
Study population and sampling
We used cross-sectional data of the population based
KORA FF4 study (Cooperative Health Research in the
Region of Augsburg) that was conducted in southern
Germany from 2013 to 2014. KORA FF4 included 2279
participants and is the second follow-up study to the
population based KORA S4 study that was conducted
from 1999 to 2001 (n = 4261). KORA is a regional
research platform for population-based surveys and sub-
sequent follow-up studies in the fields of epidemiology,
health economics, and healthcare research. A subsample
from the FF4 study (those aged between 48 to 68 years)
was designated to participate in the “Lung health &
physical activity” examination and was asked to take part
in the PA assessment by an accelerometer, of which 477
provided valid measurements and were included in this
analysis.
Detailed information about the study design, sampling
methods, response rates and dropouts of the FF4 study
and the accelerometer assessment in the subsample are
described in Kowall et al. and Luzak et al. [15].
Assessment of physical activity
Questionnaire
Sports related PA was assessed by two questions: “How
often do you exercise during winter?” and, “How often
do you exercise during summer?”. The possible re-
sponses for each question were “regularly more than two
hours per week”, “regularly one to two hours per week”,
“less than one hour per week” and “no activity”. The two
responses for summer and winter were then combined
[see Additional file 1] to a variable that was categorized
with (1) “high activity”, (2) “moderate activity”, (3) “low
activity” and (4) “no activity”. This question has been
validated by using a physical activity diary as a compari-
son [16].
Accelerometer
The participants received the accelerometer and instruc-
tions on its use at the study centre. The measurement of
PA was obtained from ActiGraph GT3X (Pensacola,
Florida) accelerometers with the use of the ActiLife soft-
ware (version 6.11.2, firmware 4.4.0). The accelerations
were sampled at 30 Hz, stored in 1 s epochs and
resampled in 1 minute epochs for further data analysis
with data filtering set to normal as recommended by
ActiGraph. The accelerometer was attached to an elastic
belt and worn at the hip side of the dominant hand. Par-
ticipants were asked to wear the accelerometer for 7 days
from getting up to going to sleep and to report
non-wear time. A non-wear time algorithm, based on
the NHANES algorithm [17], was applied to assess
non-wear time in the accelerometer data. Differences
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between the non-wear time algorithm applied to the ac-
celerometer data and the non-wear time reported in the
diary that were > 60 min (if the non-wear time was
reported in the diary) or > 120 min (if non-wear time
was indicated by the accelerometer) led to exclusion of
this day. Further exclusion criteria were non-wear time
during reported exercise in the diary > 2 h, missing in-
formation on day length, and wear time < 10 h/day. De-
tailed exclusion criteria have been previously published
[18]. Valid measurements included at least three valid
weekdays and one valid weekend day [18]. We used the
uniaxial counts (counts/min) on the vertical axis for the
deduction of the activity levels. The cut-offs were based
on those used by Freedson et al. [19]: a light intensity ac-
tivity level for > 100 to ≤1951 cpm and a moderate to
vigorous activity level (MVPA) for > 1951 cpm. The
obtained minutes spent in light intensity PA or MVPA
were summed and averaged over the participants record-
ing period, resulting in average minutes/day spent in
light intensity PA and MVPA for each participant.
According to their mean minutes per day for light
intensity PA and separately for MVPA, male and female
participants were categorized into four sex-specific activ-
ity quartiles (very low, low, high, very high). We ex-
cluded one individual with extreme body weight (BMI >
60 kg/m2) and one with an extreme value of more than
200 min/day in MVPA. More detailed information about
the PA assessment with accelerometer in the KORA FF4
population has been described elsewhere [18].
Steps per day as a global indicator for the overall
volume of PA were measured and participants were cat-
egorized into being active or inactive with reaching the
threshold of 10,000 steps per day [20, 21]. According to
the WHO PA recommendation, we additionally used the
threshold of ≥150 min/week of MVPA spent in at least
10-min bouts as another overall measure of physical
activity [11].
Assessment of direct healthcare costs
Participants were asked to report the type and num-
ber of outpatient physician and ambulatory hospital
visits in the previous 3 months [22], the number of
inpatient hospital days and days in rehabilitation in
the last 12 months, and the use of pharmaceuticals in
the previous 7 days (assessed via the information on
name, pharmaceutical identification number). All
utilization (physician visits, ambulatory hospital visits,
and drugs), if not already reported over one-year (in-
patient hospital visits and rehabilitation), were extrap-
olated to a one-year period.
To calculate direct healthcare costs, the frequency
of service use was multiplied by the unit costs pro-
vided by Bock et al. [23] and all prices refer to the
year 2013 [see Additional file 2]. For this monetary
valuation of health services, national unit costs were
applied as recommended by the Working Group
Methods in Health Economic Evaluation (AG MEG)
[24]. As the reason for hospitalization was not avail-
able, hospital days were valued using mean costs per
day as suggested by the AG MEG. All unit costs [see
Additional file 2] were updated to the costing year
2013. For our analysis, we included costs of 15
different physicians (GPs and specialists). The ex-
trapolated utilization of each physician over 1 year
was then multiplied by the unit costs specifically for
each type of physician. The number of ambulatory
hospital stays, inpatient hospital stays and rehabilita-
tion over a one-year period were also multiplied with
the corresponding unit costs. Drug utilization was
calculated with the defined daily dose (DDD) calcu-
lation and the calculation was limited to prescribed
drugs only. The cost of medication was estimated
using the pharmacy retail prices from the Scientific
Institute of the AOK healthcare insurance (WIdO)
and the price index calculator of the Federal Statis-
tical Office. Total direct medical costs were then cal-
culated as the sum of the above-mentioned cost
categories over a one-year period. A more detailed
description of the calculation of the direct costs in
the KORA cohort has been reported elsewhere [25].
Covariates
In our study, all information (except accelerometer data)
was either gathered by trained staff during a standardized
face-to-face interview or by self-report questionnaire. We
defined education by primary (< 9 years), secondary
(10 years), and tertiary (> 10 years) education and assessed
the equivalence income as measures of socio economic
status [26]. Furthermore, we differentiated among never,
former and active smokers. Reported daily alcohol con-
sumption was transformed into a binary variable indicat-
ing elevated alcohol consumption as > 12 g/day for
women and > 24 g/day for men [27]. For self-reported in-
formation on history of myocardial infarction (MI), stroke,
cancer, diabetes and asthma binary variables (yes-no) were
coded. Problems in walking were assessed with a question
from the EQ-5D-5 L questionnaire (item mobility) and all
subjects who reported moderate, or severe problems with
walking or who reported to be unable to walk about were
grouped as subjects who had problems with walking.
Statistical analysis
Cost data typically present challenges because of their
skewness and a high percentage of zeros. We decided
to use a two-part gamma model since zero-costs were
reported by 17.2% of the participants and the cost
distribution was highly right-skewed. Resulting mean
Karl et al. BMC Public Health  (2018) 18:966 Page 3 of 11
costs were estimated through recycled predictions
from 500 bootstrapping replications. Extreme values
(i.e. > 99th percentile) were replaced by the value of
the 99th percentile in order to avoid outliers due to
recall bias.
In order to have a better understanding of the as-
sociation between PIA and direct healthcare costs,
an overview of potential confounders and mediators
is represented in Additional file 3. Analyses were
performed with two sets of covariates. In Model A
we adjusted for age, age2, sex, education and income.
Underlying diseases might have influenced the par-
ticipants’ PA and healthcare costs. Thus, they need
to be considered as possible confounders to the as-
sociation between PA and direct healthcare costs.
Therefore, we adjusted Model B for chronic diseases
(diabetes, asthma, stroke, MI and cancer). Addition-
ally, Model B was adjusted for known risk factors
(smoking status and alcohol consumption). We ex-
cluded participants with chronic diseases (i.e. dia-
betes, asthma, stroke, MI, and cancer) in a third
model (Model C) in order to investigate the associ-
ation of PA and direct healthcare costs in a sup-
posedly “healthy” population. In Model D, we
adjusted for the variables from Model A but ex-
cluded all subjects who reported problems with
walking to address reverse causation.
The mean wear time in individuals with very high
MVPA equaled 923 min ± 65 min and 911 min ± 63 min
in individuals with very low MVPA. Overall, there was
no significant difference in wear time between the four
MVPA subgroups (p-value = 0.44). In participants with
very high light intensity PA and very low light intensity
PA the mean wear time of the device was 940 min ±
60 min and 903 min ± 69 min respectively. Overall, the
mean wear time differed significantly among the four
light intensity PA subgroups (p-value < 0.001). There-
fore, Model E was similar to Model A, but additionally
adjusted for wear time and therefore only applied to the
subset. Finally, Model F was only applied to the MVPA
and light intensity PA domains of the subset as it was
also similar to Model A but in case of MVPA addition-
ally adjusted for light intensity PA and vice versa.
Statistical analyses were performed using SAS software
(SAS Institute Inc., Cary, NC, USA, Version 9.2).
Results
Description of the study population
We included n = 2279 subjects in our study with a mean
age of 60 ± 12 years of which 52% were female and ac-
cording to their self-reported PA status, the sample was
distributed the following: 26% with high activity, 31%
with moderate, 14% with low and 28% with no sports ac-
tivity (Table 1).
In the subsample (n = 477) 53% were female, the mean
age was 58 ± 6 years and subjects were equally distrib-
uted into quartiles concerning their status in MVPA or
in light intensity PA (Table 2). Compared to the total
sample, subjects in the subsample had comparable char-
acteristics concerning education status, smoking status
and alcohol consumption and underlying disease status.
Regression analysis with self-reported physical activity
Table 3 shows the results of the two-part gamma regres-
sion model for the total sample with self-reported PA
where subjects with the highest activity are the reference
group and excess costs (cost differences) are reported
for subjects in the lower activity groups. The estimated
adjusted mean direct costs in the different PA groups
are illustrated in Fig. 1.
When adjusted for age, age2, sex, education and
equivalence income (Model A) the excess direct health-
care costs were insignificantly higher [€189, 95% CI:
-188, 598] in reference to the subjects with high activity
in sports [€1700, 95% CI: 1423, 1996]. In Model B, the
difference between individuals with high and no PA was
smaller and also insignificant. In the analysis with Model
C, where subjects with stroke, MI, diabetes, cancer, and
asthma were excluded, inactive participants had the low-
est overall costs, but this difference was also insignificant
[€-167, 95% CI: -531, 197].
Regression analysis with accelerometer data
Table 4 shows the results of the two-part gamma regres-
sion model for the subsample with accelerometer data
where subjects with the highest activity were the refer-
ence group and excess costs are reported for subjects in
the lower activity groups. An overview on overall direct
costs for MVPA and light intensity PA groups that re-
sulted from the different models is shown in Fig. 2.
Device assessed MVPA
In this domain, results showed consistently that partici-
pants with very low MVPA had higher direct healthcare
costs. When adjusted for age, age2, sex, education and
equivalence income (Model A) the excess costs of partic-
ipants with very low MVPA overall direct healthcare
costs were €986 [15, 1982] in reference to participants
with very high MVPA [€1276, 95% CI: 841, 1759]. The
results were similar when adding wear time (Model E)
or light intensity PA (Model F) as covariates.
Device assessed light intensity PA
The association with light intensity PA was qualitatively
similar to the association with MVPA, with people with
very low light intensity PA having the highest direct
healthcare costs. However, this association was only
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significant for Model C, where we excluded participants
with chronic conditions [€912, 95% CI: 29, 1986].
Device assessed steps per day
Concerning steps per day (more than or less than 10,000
steps per day), inactive participants had higher direct
healthcare costs as compared to active subjects (Model A).
However, this difference was not statistically significant.
Device assessed WHO PA threshold
The direct healthcare costs of those participants, who
achieved the WHO recommendation [1], i.e. those who
reached at least 150 min of MVPA in ≥10-min bouts,
were not significantly different, but always higher, to the
ones that did not reach the WHO threshold.
Discussion
This study aimed to analyze the association between de-
vice assessed and self-reported PA and direct healthcare
costs in a population-based sample. Device assessed but
not self-reported PA was associated with lower direct
healthcare costs. The size of the effect was dependent on
the type of model used to calculate the costs attributable
to PIA.
It is difficult to compare the findings of this study
with other studies assessing PIA and direct healthcare
costs because of the numerous different methods that
have been used to calculate direct healthcare costs
and to assess or estimate PIA [4, 5, 11, 28]. Still, this
study is partly in line with other international studies
that report higher direct healthcare expenditures for
inactive as compared to active subjects [11, 28]. For
example, Carlson et al. [11] also investigated
self-reported PA and direct healthcare expenditures in
the U.S. In this study, PA was assessed by asking
adults how often and, if applicable, how long during
leisure-time they participated in vigorous-intensity ac-
tivities and in light- or moderate-intensity activities of
at least 10 min duration. Respondents were then clas-
sified into three activity levels: active, with 150 min/
week of moderate-intensity equivalent physical activ-
ity, as recommended by the WHO [1], insufficiently
active, i.e. those below this threshold, and inactive,
reporting no moderate-intensity equivalent that lasted
at least 10 min. Carlson et al. [11] also investigated
the relation between PA and direct healthcare costs
in a population aged 21 years or older (49.8% females).
More than one-third of the participants reported being
Table 1 Description of the total study sample of KORA FF4 and self-reported physical activity groups with means or frequencies
(standard deviations or percentages)
Variable Physical activity during sports
High activity Moderate activity Low activity No activity
N 2279 596 (26.2) 709 (31.1) 329 (14.4) 645 (28.3)
Age 60.2 (12.3) 59.4 (11.5) 59.1 (11.9) 59.3 (12.1) 62.9 (13.2)
Sex
Female 1177 (51.6) 284 (47.7) 410 (57.8) 174 (52.9) 309 (47.91)
Education
Primary 1110 (48.8) 224 (37.7) 327 (46.12) 186 (56.7) 373 (58.0)
Secondary 585 (25.7) 172 (29.0) 200 (28.2) 79 (24.1) 134 (20.8)
Tertiary 579 (25.4) 198 (33.3) 182 (25.7) 63 (19.2) 136 (21.2)
Equivalence Income 1460.1 (679.7) 1576.3 (692.1) 1533.1 (668.2) 1386.9 (712.6) 1307.5 (629.9)
Diseases 671 (29.4) 164 (27.5) 183 (25.8) 108 (32.8) 216 (33.5)
MI 79 (3.5) 19 (3.2) 16 (2.3) 12 (3.7) 32 (5.0)
Stroke 63 (2.8) 13 (2.2) 13 (1.8) 7 (2.1) 30 (4.7)
Cancer 257 (11.3) 71 (11.9) 64 (9.0) 40 (12.2) 82 (12.7)
Diabetes 233 (10.2) 41 (6.9) 50 (7.1) 41 (12.5) 101 (15.7)
Asthma 201 (8.8) 53 (8.91) 64 (9.0) 26 (7.9) 58 (9.0)
Smoking
Never 947 (41.5) 230 (38.6) 331 (46.7) 126 (38.3) 260 (40.3)
Former 980 (43.0) 285 (47.8) 284 (40.1) 146 (44.4) 265 (41.1)
Yes 352 (15.5) 81 (13.6) 94 (13.3) 57 (17.3) 120 (18.6)
Elevated alcohol consumption 675 (29.6) 199 (33.5) 214 (30.2) 90 (27.4) 172 (26.7)
Problems with walking 199 (8.8) 24 (4.1) 44 (6.2) 35 (10.7) 96 (15.1)
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inactive, compared to 28.3% participants in our study re-
ported to be inactive. Concerning the accelerometer data,
the low adherence of this study population to the WHO
PA recommendations that has been described elsewhere
by Luzak et al. [18] is comparable to other European
populations.
Another important issue of interest we tried to address
was the various sources of confounding in the relation-
ship between PIA and direct healthcare costs. Our as-
sumption is that inactive subjects cause more direct
healthcare costs than active participants, but we cannot
exclude the fact that there might be participants who are
inactive due to a sickness or disability (exposure) that in-
fluence their PA (outcome). One way to address this
issue is to exclude participants who report having prob-
lems with walking or being unable to do PA [11]. There-
fore, we excluded participants who reported walking
problems in Model D. In Model D the observed differ-
ence in direct healthcare costs was not statistically sig-
nificant but still present.
Another way to address the confounding problem
would be to use longitudinal panel data. By having infor-
mation about the timely order of PA and direct health-
care costs it would be easier to disentangle the direction
of the association and to control for confounding fac-
tors. Ideally, for this one would combine representative
population-based data from various follow up examina-
tions with health insurance claims data that provide
granular information on the trend of direct healthcare
costs over time.
Strengths and limitations
This paper has several limitations. First, the present re-
sults, including subjects of KORA FF4 with a response
of 68% limiting the general external validity. Second, our
results are based on cross-sectional data, which does not
give information about long-term PIA behavior or
change of PIA during the time that plays an important
role in relation to direct healthcare costs.
Table 3 Overall direct costs (€) associated with PIA estimated with the different models in the total sample
Variable Physical activity during sports
High activity (Ref. [95% CI]) Moderate activity (β [95% CI]) Low activity (β [95% CI]) No activity (β [95% CI])
Model Aa 1700 [1423, 1996] 84 [− 346, 459.8] 275 [− 212.6–836.6] 189 [−188–598]
Model Bb 1783 [1527, 2089] 125 [− 260, 509] 206 [−357–730] 6 [−423–391]
Model Cc 1314 [1045, 1604] −66 [− 431, 298] 143 [− 374–698] −167 [− 531–197]
Model Dd 1481 [1225, 1759] 109 [− 225, 437] 189 [− 287–679] 33 [− 365–382]
The highest level of PA was used as a reference within all four different measures of PA. Therefore, the values in the respective columns (Ref.) represent a mean
estimate whereas the values in the other columns (β) represent coefficients
aModel A: adjusted for age, age2, sex, education and equivalence income;
bModel B: adjusted for variables in Model A plus diabetes, asthma, MI, stroke, cancer, smoking status and alcohol consumption;
cModel C: adjusted for variables in Model A & exclusion of participants with prevalent chronic diseases mentioned in Model B (n = 1608);
dModel D: adjusted for variables in Model A & exclusion of participants with problems with walking (n = 2059);
** p < 0.05, * trend with p < 0.10
Fig. 1 Mean overall direct healthcare costs of self-reported physical activity groups in the total sample - Results from a two-part gamma
regression model
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In addition, this study did not include indirect
costs, which covers loss of productivity from prema-
ture death or work absenteeism. The authors are also
aware that a constant utilization of health services
was assumed in the present study when reported uti-
lizations were extrapolated to a one-year period,
which tends to underestimate the actual utilization
over one year [29].
A major strength of this study is, that it provides
insight into the relationship between self-reported and
device assessed PIA and direct healthcare costs and
that it is based on a relatively large population-based
sample. Another strength of this study is the estima-
tion of various alternative models to assess the ro-
bustness of the results with regard to confounding
factors.
Fig. 2 Mean overall direct healthcare costs of device assessed physical activity groups in the subsample - Results from a two-part gamma
regression model
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Conclusions
The results indicate that device assessed but not
self-reported PIA is associated with higher direct health-
care costs. Larger studies with device assessed PA and
longitudinal design are needed to better quantify the im-
pact of PIA on direct healthcare costs.
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